Document is current
Any future updates will be listed below
-
Authors
Hjermstad, Marianne Jensen
Aass, Nina
Andersen, Sigve
Brunelli, Cinzia
Dajani, Olav
Garresori, Herish
Hamre, Hanne
Haukland, Ellinor C.
Holmberg, Mats
Jordal, Frode
Krogstad, Hilde
Lundeby, Tonje
Løhre, Erik Torbjørn
Mjåland, Svein
Nordbø, Arve
Paulsen, Ørnulf
Schistad Staff, Erik
Wester, Torunn
Kaasa, Stein
Loge, Jon Håvard
-
Funding
Funding for this research was provided by:
Helse Sør-Øst RHF (14/01152-5)
- License Information
-
More Information
Article History
Received: 18 December 2019
Accepted: 2 March 2020
First Online: 2 April 2020
Ethics approval and consent to participate
: This trial is conducted in accordance with ethical principles according to the Declaration of Helsinki. It is further in accordance with Good Clinical Practice and all Norwegian regulatory requirements for study conduct. All participants, i.e. patients and caregivers, must provide their written informed consent before study inclusion, after being informed in oral and writing by study personnel. As caregivers are approached also after the patient’s death, a new consent form is provided.Ethical approval of the final version of this protocol (16 December 2016) was confirmed from the Regional Committee for Medical and Health Research Ethics (REC) in South East Norway (RefID: 2016/1220-PALLiON) and submitted to the other regional REC committees upon request, which is valid for all Norwegian institutions. The trial was registered in the database (No. ) in March 2017.
: Not applicable.
: The authors declare that they have no competing interests.
